Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Loss to follow-up in an international, multicentre observational study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The HepHIV 2017 Conference in Malta: joining forces for the earlier diagnosis of HIV and viral hepatitis

    Research output: Contribution to journalReviewResearchpeer-review

  3. HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The effect of interrupted/deferred antiretroviral therapy on disease risk: a SMART & START combined analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hyaluronic Acid Is a Biomarker for Allograft Dysfunction and Predicts 1-Year Graft Loss After Liver Transplantation

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Brief Report: Prevalence of Peripheral Artery Disease is Higher in Persons Living with HIV Compared to Uninfected Controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Febrile Neutropenia and Long-term Risk of Infection Among Patients Treated With Chemotherapy for Malignant Diseases

    Research output: Contribution to journalJournal articleResearchpeer-review

  • A Mocroft
  • O Kirk
  • P Aldins
  • A Chies
  • A Blaxhult
  • N Chentsova
  • N Vetter
  • F Dabis
  • J Gatell
  • J D Lundgren
  • NN NN
View graph of relations
OBJECTIVE: The aim of this work was to assess loss to follow-up (LTFU) in EuroSIDA, an international multicentre observational cohort study. METHODS: LTFU was defined as no follow-up visit, CD4 cell count measurement or viral load measurement after 1 January 2006. Poisson regression was used to describe factors related to LTFU. RESULTS: The incidence of LTFU in 12 304 patients was 3.72 per 100 person-years of follow-up [95% confidence interval (CI) 3.58-3.86; 2712 LTFU] and varied among countries from 0.67 to 13.35. After adjustment, older patients, those with higher CD4 cell counts, and those who had started combination antiretroviral therapy all had lower incidences of LTFU, while injecting drug users had a higher incidence of LTFU. Compared with patients from Southern Europe and Argentina, patients from Eastern Europe had over a twofold increased incidence of LTFU after adjustment (incidence rate ratio 2.16; 95% CI 1.84-2.53; P<0.0001). A total of 2743 patients had a period of >1 year with no CD4 cell count or viral load measured during the year; 743 (27.1%) subsequently returned to follow-up. CONCLUSIONS: Some patients thought to be LTFU may have died, and efforts should be made to ascertain vital status wherever possible. A significant proportion of patients who have a year with no follow-up visit, CD4 cell count measurement or viral load measurement subsequently return to follow-up.
Original languageEnglish
JournalHIV Medicine
Volume9
Issue number5
Pages (from-to)261-9
Number of pages8
ISSN1464-2662
DOIs
StatePublished - 2008

    Research areas

  • Adult, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Europe, Female, Follow-Up Studies, HIV Infections, HIV-1, Humans, Incidence, Male, Regression Analysis, Viral Load

ID: 32533550